September 27, 2016 Angry about high-priced EpiPens? Blame cronyism and overregulation Pharmaceutical company Mylan recently spurred a flurry of outrage after raising the price of their lifesaving EpiPen by 400%, leading many to decry “corporate greed” and point the finger at capitalism. Continue Reading...